Showing 1 to 12 of 12 results
China Approves First Domestic 9-Valent HPV Vaccine
China approved Cecolin 9, its first domestically developed 9-valent HPV vaccine, addressing a market previously dominated by foreign companies; this follows over 18 years of research and multiple clinical trials, and aims to reduce cervical cancer risk significantly by expanding vaccination access.
China Approves First Domestic 9-Valent HPV Vaccine
China approved Cecolin 9, its first domestically developed 9-valent HPV vaccine, addressing a market previously dominated by foreign companies; this follows over 18 years of research and multiple clinical trials, and aims to reduce cervical cancer risk significantly by expanding vaccination access.
Progress
44% Bias Score
Declining HPV Vaccination Rates Threaten England's Cervical Cancer Elimination Plan
A decline in HPV vaccination rates among children in England, falling 17 percentage points since the pandemic, threatens the country's plan to eliminate cervical cancer by 2040, as HPV causes 99 percent of cervical cancer cases. The decline is attributed to parents' hesitancy and "vaccine fatigue", ...
Declining HPV Vaccination Rates Threaten England's Cervical Cancer Elimination Plan
A decline in HPV vaccination rates among children in England, falling 17 percentage points since the pandemic, threatens the country's plan to eliminate cervical cancer by 2040, as HPV causes 99 percent of cervical cancer cases. The decline is attributed to parents' hesitancy and "vaccine fatigue", ...
Progress
40% Bias Score
China Approves Gardasil®9 for Males, Expanding HPV Vaccine Access
China approved MSD's Gardasil®9 HPV vaccine for males aged 16-26, becoming the first and only nine-valent vaccine approved for both sexes in the country, expanding prevention of HPV-related cancers and diseases.
China Approves Gardasil®9 for Males, Expanding HPV Vaccine Access
China approved MSD's Gardasil®9 HPV vaccine for males aged 16-26, becoming the first and only nine-valent vaccine approved for both sexes in the country, expanding prevention of HPV-related cancers and diseases.
Progress
56% Bias Score
HPV Vaccine Underutilization Leads to Preventable Cancer Deaths
Chris Riley's death from HPV-related oropharyngeal cancer highlights the critical need for increased HPV vaccination rates in the U.S., where only about 61% of adolescents ages 13-17 have completed the series, despite the vaccine's ability to prevent approximately 90% of HPV-related cancers.
HPV Vaccine Underutilization Leads to Preventable Cancer Deaths
Chris Riley's death from HPV-related oropharyngeal cancer highlights the critical need for increased HPV vaccination rates in the U.S., where only about 61% of adolescents ages 13-17 have completed the series, despite the vaccine's ability to prevent approximately 90% of HPV-related cancers.
Progress
64% Bias Score
HPV Vaccine Significantly Reduces Cervical Cancer Risk in Young Women
The CDC reports an 80% reduction in precancerous cervical lesions among vaccinated 20-24 year-old women from 2008-2022, contrasting with US Health Secretary Robert Kennedy Jr.'s stance against the HPV vaccine, despite his financial ties to lawsuits against the vaccine manufacturer.
HPV Vaccine Significantly Reduces Cervical Cancer Risk in Young Women
The CDC reports an 80% reduction in precancerous cervical lesions among vaccinated 20-24 year-old women from 2008-2022, contrasting with US Health Secretary Robert Kennedy Jr.'s stance against the HPV vaccine, despite his financial ties to lawsuits against the vaccine manufacturer.
Progress
40% Bias Score
China Approves HPV Vaccine for Males
On January 9th, 2025, China administered its first HPV vaccine dose to a man in Changsha, Hunan province, expanding access to Merck's Gardasil vaccine for males aged 9-26 to prevent HPV-related cancers and genital warts.
China Approves HPV Vaccine for Males
On January 9th, 2025, China administered its first HPV vaccine dose to a man in Changsha, Hunan province, expanding access to Merck's Gardasil vaccine for males aged 9-26 to prevent HPV-related cancers and genital warts.
Progress
36% Bias Score
China Approves First Domestic 9-Valent HPV Vaccine
China approved its first domestically developed 9-valent HPV vaccine, Cecolin 9, ending over a decade of foreign market dominance; the vaccine protects against nine strains of HPV and has shown a favorable safety profile in clinical trials, aligning with China's plan to eliminate cervical cancer by ...
China Approves First Domestic 9-Valent HPV Vaccine
China approved its first domestically developed 9-valent HPV vaccine, Cecolin 9, ending over a decade of foreign market dominance; the vaccine protects against nine strains of HPV and has shown a favorable safety profile in clinical trials, aligning with China's plan to eliminate cervical cancer by ...
Progress
44% Bias Score
Family Urges HPV Vaccination After Daughter's Death
The family of a 25-year-old woman who died from cervical cancer in 2012 due to HPV are urging parents to vaccinate their children after the virus was found to be responsible for her death. The HPV vaccine has been available in the UK since 2008 for girls and 2019 for boys.
Family Urges HPV Vaccination After Daughter's Death
The family of a 25-year-old woman who died from cervical cancer in 2012 due to HPV are urging parents to vaccinate their children after the virus was found to be responsible for her death. The HPV vaccine has been available in the UK since 2008 for girls and 2019 for boys.
Progress
48% Bias Score
India Trains 100,000 Doctors to Promote HPV Vaccine to Eliminate Cervical Cancer
India is training 100,000 doctors to promote the HPV vaccine to eliminate cervical cancer, which accounts for 20% of global cases, with the government expected to include it in its national vaccination program in 2024, addressing low uptake and misinformation.
India Trains 100,000 Doctors to Promote HPV Vaccine to Eliminate Cervical Cancer
India is training 100,000 doctors to promote the HPV vaccine to eliminate cervical cancer, which accounts for 20% of global cases, with the government expected to include it in its national vaccination program in 2024, addressing low uptake and misinformation.
Progress
40% Bias Score
HPV Vaccine Significantly Reduces Cervical Precancer in Young U.S. Women
A Centers for Disease Control and Prevention report shows an approximately 80% reduction in cervical precancerous cells among 20- to 24-year-old women in the U.S. between 2008 and 2022, strongly correlating with the introduction of the HPV vaccine in 2006.
HPV Vaccine Significantly Reduces Cervical Precancer in Young U.S. Women
A Centers for Disease Control and Prevention report shows an approximately 80% reduction in cervical precancerous cells among 20- to 24-year-old women in the U.S. between 2008 and 2022, strongly correlating with the introduction of the HPV vaccine in 2006.
Progress
52% Bias Score
HPV Vaccine Shows Promise in Eliminating Cervical Precancer
A Dutch trial found that an HPV vaccine (Vvax001) eliminated high-risk cervical precancerous cells (CIN3) in half of 18 participants, potentially replacing the invasive loop excision surgery; after 19 weeks, nine saw their cells shrink or vanish, with three cases showing complete destruction, and no...
HPV Vaccine Shows Promise in Eliminating Cervical Precancer
A Dutch trial found that an HPV vaccine (Vvax001) eliminated high-risk cervical precancerous cells (CIN3) in half of 18 participants, potentially replacing the invasive loop excision surgery; after 19 weeks, nine saw their cells shrink or vanish, with three cases showing complete destruction, and no...
Progress
40% Bias Score
Global Push to Eliminate Cervical Cancer
Global Day of Action for Cervical Cancer Elimination urges G20 leaders to increase access to vaccines, screening, and treatment to eliminate cervical cancer.
Global Push to Eliminate Cervical Cancer
Global Day of Action for Cervical Cancer Elimination urges G20 leaders to increase access to vaccines, screening, and treatment to eliminate cervical cancer.
Progress
32% Bias Score
Showing 1 to 12 of 12 results